July 3, 2014 / 9:52 AM / 3 years ago

CORRECTED-FDA says manufacturing issues at St. Jude plant resolved

1 Min Read

(Corrects second paragraph to remove reference to "Riata" leads)

July 2 (Reuters) - St. Jude Medical Inc said the U.S. Food and Drug Administration notified the company that issues regarding its Sylmar, California-based manufacturing plant have been resolved.

The FDA last year had warned St. Jude of serious violations at the plant where the Durata leads implantable defibrillators are made. Violations included a failure to validate testing methods. (Reporting by Natalie Grover in Bangalore; Editing by Joyjeet Das)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below